Literature DB >> 32661663

Chemokines and Bone.

Annette Gilchrist1.   

Abstract

Chemokines are a family of small proteins, subdivided by their conserved cysteine residues and common structural features. Chemokines interact with their cognate G-protein-coupled receptors to elicit downstream signals that result in cell migration, proliferation, and survival. This review presents evidence for how the various CXC and CC subfamily chemokines influence bone hemostasis by acting on osteoclasts, osteoblasts, and progenitor cells. Also discussed are the ways in which chemokines contribute to bone loss as a result of inflammatory diseases such as rheumatoid arthritis, HIV infection, and periodontal infection. Both positive and negative effects of chemokines on bone formation and bone loss are presented. In addition, the role of chemokines in altering the bone microenvironment through effects on angiogenesis and tumor invasion is discussed. Very few therapeutic agents that influence bone formation by targeting chemokines or chemokine receptors are available, although a few are currently being evaluated.

Entities:  

Keywords:  Chemokine; Chemokine receptor; G-protein-coupled receptor; Hematopoietic stem cell; Mesenchymal stem cell; Osteoblast; Osteoclast; Osteoimmunology

Mesh:

Substances:

Year:  2020        PMID: 32661663     DOI: 10.1007/164_2020_349

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  3 in total

1.  A Study of IFN-α-Induced Chemokines CCL2, CXCL10 and CCL19 in Patients with Systemic Lupus Erythematosu.

Authors:  Mariela Gencheva Geneva-Popova; Stanislava Dimitrova Popova-Belova; Petya Nikolova Gardzheva; Krasimir Iliev Kraev
Journal:  Life (Basel)       Date:  2022-02-08

Review 2.  Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma.

Authors:  Annette Gilchrist; Stephanie L Echeverria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-25       Impact factor: 5.555

Review 3.  The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker.

Authors:  Yudie Yan; Jingtong Su; Zhen Zhang
Journal:  Cell Mol Neurobiol       Date:  2021-06-12       Impact factor: 4.231

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.